Skip to main content
Contact Us
Subscribe
E-Edition
72°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LILLY DRN
Recent news which mentions LILLY DRN
< Previous
1
2
Next >
Hims & Hers shares rise as company adds new weight-loss medications to platform
Today 15:21 EDT
Tags
Enterprise
LILLY DRN
Hims & Hers Health Inc
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Today 14:01 EDT
Tags
Moderna Inc
Vertex Pharmaceuticals Inc
Abbvie Inc
From
CNBC.com News
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Today 13:47 EDT
Tags
Health & Science
AstraZeneca PLC
Health care industry
From
CNBC.com News
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Today 8:38 EDT
Tags
Health care industry
Business
Social issues
From
CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
March 29, 2025
Tags
Pharmaceuticals
Companies
Health care industry
From
CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
March 28, 2025
Tags
LILLY DRN
Biotechnology
Pharmaceuticals
From
CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
March 27, 2025
Tags
Biotech and Pharmaceuticals
Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
March 25, 2025
Tags
Biotech and Pharmaceuticals
Healthy Returns
LILLY DRN
From
CNBC.com News
5 things to know before the stock market opens Tuesday
March 25, 2025
Tags
Tesla Inc
Investment strategy
5 Things to Know
From
CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
March 24, 2025
Tags
Pfizer Inc
Health care industry
Pharmaceuticals
From
CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
March 24, 2025
Tags
Business
Pharmaceuticals
Biotech and Pharmaceuticals
From
CNBC.com News
Beijing pledges greater market access as top global CEOs gather at the China Development Forum
March 24, 2025
Tags
U/S/ Markets
Honeywell International Inc
China Markets
From
CNBC.com News
Zepbound copycats remain online despite FDA ban
March 21, 2025
Tags
Pharmaceuticals
Health care industry
Hims & Hers Health Inc
From
CNBC.com News
Roche and Zealand Pharma strike $5.3 billion deal for new obesity drug candidate
March 12, 2025
Tags
Biotechnology
Pharmaceuticals
LILLY DRN
From
CNBC.com News
White House: Stock market plunge is not as 'meaningful' as business activity
March 10, 2025
Tickers
CEOS
Tags
Markets
CEOs
Breaking News: Markets
From
CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
March 05, 2025
Tags
Health & Science
Business
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
March 05, 2025
Tags
Breaking News: Business
US: News
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
March 04, 2025
Tags
Amazon/com Inc
GE HealthCare Technologies Inc
Healthy Returns
From
CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
February 26, 2025
Tags
Pharmaceuticals
Companies
Health care industry
From
CNBC.com News
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
February 25, 2025
Tags
Companies
Pharmaceuticals
Health care industry
From
CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
February 21, 2025
Tags
Health & Science
Business
Biotech and Pharmaceuticals
From
CNBC.com News
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall
February 20, 2025
Tags
Health & Science
Biotech and Pharmaceuticals
LILLY DRN
From
CNBC.com News
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
February 20, 2025
Tags
Health & Science
Biotech and Pharmaceuticals
LILLY DRN
From
CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
Tags
Health care industry
Health & Science
Social issues
From
CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
February 13, 2025
Tags
Europe Economy
U/S/ Economy
US Economy
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 06, 2025
Tags
Yum! Brands Inc
Business
Peloton Interactive Inc
From
CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
February 06, 2025
Tags
Business
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
February 06, 2025
Tags
Biotechnology
Business News
Earnings
From
CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
February 05, 2025
Tags
Health & Science
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
February 05, 2025
Tags
Europe Economy
Business
Pharmaceuticals
From
CNBC.com News
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.